The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Allay Therapeutics has dosed the first subject in the randomised Phase IIb registration trial of its investigational ...

From soothing toothaches to calming migraines, discover how everyday kitchen ingredients are proving more effective than ...

The "Analgesics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global ...

Providing pain relief during surgical animal husbandry procedures is a better choice for your livestock, your business and ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management an ...

Additionally, the development of combination drugs that incorporate multiple analgesics into a single dose has enhanced pain relief outcomes by targeting different pain pathways simultaneously.

On February 17, VIVOZON Pharmaceutical announced that its non-opioid analgesic, UNAFRA Inj., was approved on December 12, 2024. (active ingredient: Opiranserin HCl), has received approval from the ...

Cannabidiol (CBD) may offer numerous health benefits, including pain reduction and anxiety relief, without the intoxicatingly psychoactive effects of delta-9 tetrahydrocannabinol (THC).